B
AKRO

Braidwell’s Akero Therapeutics AKRO Stock Holding History

Braidwell’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-475,400
Closed -$22.6M – 74
2025
Q3 		$22.6M Buy
+475,400
New +$23M 0.67% 43
2024
Q3 		– Sell
-1,084,400
Closed -$25.4M – 82
2024
Q2 		$25.4M Buy
+1,084,400
New +$23.2M 0.8% 43

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Braidwell's AKRO Position: Q4 2025 in Review

Braidwell sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 475,400 shares — an estimated $22.6M sold.

Braidwell first reported a position in AKRO in Q2 2024 and held it in 2 quarters. The position peaked at $25.4M in Q2 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Braidwell reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Braidwell sold 475,400 Akero Therapeutics shares in Q4 2025, an estimated $22.6M.
  • Braidwell first reported a position in Akero Therapeutics in Q2 2024 and held it in 2 quarters.
  • Braidwell's Akero Therapeutics position peaked at $25.4M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Braidwell's 13F filing for Q4 2025, filed 17 Feb 2026.